Bontril Slow-Release Capsules and Parathyroid hormone Subcutaneous
Determining the interaction of Bontril Slow-Release Capsules and Parathyroid hormone Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: phendimetrazine
Brand name: Bontril, Melfiat, Bontril PDM
Synonyms: Bontril
Generic Name: parathyroid hormone
Brand name: Natpara
Synonyms: Parathyroid hormone, Parathyroid Hormone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bontril Slow-Release Capsules-Parcopa
- Bontril Slow-Release Capsules-Paregoric
- Bontril Slow-Release Capsules-Paremyd
- Bontril Slow-Release Capsules-Paremyd Ophthalmic
- Bontril Slow-Release Capsules-Paricalcitol
- Bontril Slow-Release Capsules-Paricalcitol Capsules
- Parathyroid hormone Subcutaneous-Boostrix
- Parathyroid hormone Subcutaneous-Boostrix Intramuscular
- Parathyroid hormone Subcutaneous-Boroleum
- Parathyroid hormone Subcutaneous-Bortezomib
- Parathyroid hormone Subcutaneous-Bortezomib Intravenous
- Parathyroid hormone Subcutaneous-Bosentan